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Nonenzymatically Glucosylated 
Albumin 
IN VITRO PREPARATION AND ISOLATION FROM 
NORMAL HUMAN SERUM* 
(Received for publication, November 27, 1978) 
James F. Day, Suzanne R. Thorpe, and John W. 
BaynesS 
From the Department of Chemistry and School of 
Medicine, University of South Carolina, Columbia, South 
Carolina 29208 
SUMMARY 
Incubation of human serum with u-[6-3H]glucose re- 
sulted in the gradual accumulation of radioactivity in 
acid-precipitable material. Upon chromatography on 
Sephadex G-200, radioactivity was found associated 
with each of the major molecular weight classes of 
serum protein. Purified human serum albumin was also 
glucosylated in vitro upon exposure to D-[6-3H]glucose 
in phosphate-buffered saline. The glucosylated and un- 
modified albumins were separated by ion exchange 
chromatography. The physiological significance of 
these observations in vitro was confirmed by the iso- 
lation and quantitation of glucosylated albumin from 
normal human serum. Glucosylated albumin repre- 
sents approximately 6 to 15% of total serum albumin in 
normal adults. The post-translational modification ap- 
pears to occur by a nonenzymatic process analogous to 
that responsible for glucosylation of hemoglobin A to 
hemoglobin AIM, i.e. through Schiff base formation and 
Amadori rearrangement to a ketoamine derivative. 
While the acute manifestations of diabetes (e.g. hypergly- 
cemia, glycosuria, ketoacidosis) can often be managed clini- 
cally by insulin therapy, progressive secondary complications 
are the major cause of the chronic illness and high mortality 
associated with this disease (1-3). These complications result 
primarily from severe, generalized vascular disease (microan- 
giopathy and atherosclerosis), which is most apparent in crit- 
ical organs such as the kidneys and eyes, and in the nervous 
system. There is an increasing body of evidence based on both 
clinical experience with patients (3) and animal model studies 
(4) that chronic, subclinical hyperglycemia is the major caus- 
ative factor in the secondary complications of diabetes. The 
mechanism by which hyperglycemia may induce these vas- 
cular problems is presently unknown. It has been postulated, 
however, that glucose-dependent chemical alterations in body 
proteins could cause changes in protein structure, and hence, 
function, leading to the pathophysiology of diabetes (2). The 
demonstration in diabetics of increased amounts of hemoglo- 
bin AIc, a nonenzymatically glucosylated form of hemoglobin 
A, was the first example of a protein modification correlated 
* This work was supported in part by United States Public Health 
Service Research Grant 1 ROl AM 19971. The costs of publication of 
this article were defrayed in part by the payment of page charges. 
This article must therefore be hereby marked “aduertisement” in 
accordance with 18 USC. Section 1734 solely to indicate this fact. 
$ To whom all correspondence should be addressed. 
with elevated blood glucose concentrations (5). More recently, 
Stevens et al. (6) have provided convincing evidence that 
glucosylation of lens crystallins may contribute to the devel- 
opment of cornea1 opacification in diabetics. 
The chemical reactions leading to the nonenzymatic gluco- 
sylation of protein were originally described in studies on the 
browning reactions of food proteins (7). The interaction be- 
tween glucose and protein occurs at free amino groups in the 
protein, and mechanistically, involves the free base form of 
the amine. In the case of hemoglobin, glucosylation occurs in 
uivo or in vitro by a condensation between glucose and the 
NHz-terminal valine residues of the p chains. As shown in Fig. 
1, the initial product, the Schiff base derivative of hemoglobin, 
undergoes an Amadori rearrangement to form an acid-stable 
ketoamine adduct (5). There is no a priori reason, however, 
why glucosylation should be unique to hemoglobin or crystal- 
lins, and we hypothesized that plasma proteins, which are 
normally bathed in a 5 mM glucose medium, should undergo 
similar modifications. We report here the in vitro glucosyla- 
tion of albumin and several other serum proteins, and docu- 
ment, for the first time, that 6 to 15% of human albumin in 
serum exists naturally in a glucosylated form. 
MATERIALS AND METHODS 
Human serum albumin was purified from fresh human serum by 
affinity chromatography on Affi-Gel Blue (Bio-Rad) (8), followed by 
gel chromatography on Bio-Gel P-150 (Bio-Rad). n-[6-‘HIGlucose (34 
Ci/mmol) was purchased from New England Nuclear Co. 
Incubations-Albumin solutions and human serum were sterilized 
by ultrafiltration, and incubated in the dark at room temperature. 
Albumin solutions were prepared in Dulbecco’s phosphate-buffered 
saline (9), containing 5 mM glucose. Serum was incubated under an 
atmosphere of 95% 02, 5% CO1 to maintain pH 7.3 to 7.4. Trace 
amounts of [6-“HIglucose were added to incubation mixtures to obtain 
desired specific activity. 
Assays-Acid-precipitable radioactivity was determined by adding 
25.~1 aliquots of incubation mixtures to 50 ~1 of a bovine serum 
albumin solution (10 mg/ml) and precipitating with 1 ml of cold 10% 
trichloroacetic acid. Precipitates were washed twice by dissolution in 
100 ~1 of 0.1 N NaOH and reprecipitated with acid. The washed 
precipitates were dissolved in 500 ~1 of Hz0 and counted for radioac- 
tivity in Beckman Instruments Co. Bio-Solv EP. 
Glucosylated protein was detected using the thiobarbituric acid 
procedure of Fliickiger and Winterhalter (10) which measures 5- 
hydroxymethylfurfural released upon hydrolysis of ketoamine ad- 
ducts of protein. All samples were scanned in the 400 to 500 nm 
region, yielding a X,,, a t 443 nm, characteristic of the reaction of 
thiobarbituric acid with 5-hydroxymethylfurfural. 
RESULTS 
When human serum was incubated with tracer amounts of 
[6-“HIglucose under sterile conditions, radioactivity gradually 
accumulated in an acid-precipitable fraction (Fig. 2). Accu- 
mulation of radioactivity was linear with time for at least 200 
h, and, by the end of this time, about 10% of the starting 
glucose had been transferred to acid-precipitable material. As 
a first step in the characterization of the reaction product, the 
remainder of the incubation mixture at 200 h was dialyzed. 
Essentially all of the initial acid-precipitable radioactivity in 
the incubation mixture was stable to dialysis and was nondi- 
alyzable. Upon chromatography of the dialysate on Sephadex 
G-200 (Fig. 3), radioactivity was associated with each of the 
three major molecular weight species of serum proteins. The 
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FIG. 2 (left). In vitro incorporation of acid-precipitable radioac- 
tivity into human serum incubated with [6-“HIglucose. One milliliter 
of human serum was incubated with 2 x 10’ cpm (-1 pg) of 
[6-“HIglucose at 25°C; aliquots were removed at indicated times and 
radioactivity precipitable by trichloroacetic acid was determined as 
described under “Materials and Methods”. Data are expressed as 
precipitable counts per min in total incubation. 
FIG. 3 (center). Sephadex G-200 chromatographic profile of hu- 
man serum after 8 days of incubation with [6-“Hlglucose. Human 
serum was incubated with [6-“HIglucose for 200 h, as in Fig. 2, dialyzed 
overnight at 4°C against two changes (1000 volumes) of 0.1 M Tris. 
HCl, pH 7.8, 1.0 M NaCl, and chromatographed on a G-200 column 
(1.5 x 63 cm, I ml/fraction). The column was eluted with the same 
highest specific activity was found in the region corresponding 
to authentic human albumin. For this reason, we decided to 
study the glucosylation of serum albumin itself, at physiolog- 
ical pH and electrolyte concentration in vitro. 
Monomeric human serum albumin was prepared as de- 
scribed under “Materials and Methods” and incubated with 
[G-“HIglucose. As shown in Fig. 4, incorporation of glucose 
into albumin (by acid precipitation) was linear for at least 8 
days, at which time 0.5 mol of glucose were incorporated per 
mol of albumin. This experiment with purified albumin indi- 
cates that glucosylation can proceed by a nonenzymatic mech- 
anism. Since the nucleophilic amino group of lysine 189 (pK 
E 7.9) of human serum albumin is known to be reactive to 
acetylation by aspirin (acetyl salicylate) (ll), a competition 
experiment was carried out to evaluate the possibility that 
glucosylation could also occur at that site. Addition of aspirin 
to incubations at one-tenth the concentration of glucose (Fig. 
4) resulted in a 50% inhibition of the rate of incorporation of 
[6-“HIglucose into albumin, suggesting that at least some 
glucose is being incorporated at lysine 189. 
The tentative identification of lysine 189 as one site for 
glucosylation in uitro, and the acid stability of the glucose 
linkage to albumin, suggested that albumin was being modi- 
fied by a mechanism similar to that proposed for the formation 
of hemoglobin AI, (Fig. 1). Because the Amadori rearrange- 
ment to the ketoamine adduct eliminates the chiral center at 
C-2 of glucose, both glucose and mannose are obtained upon 
hydrolysis of hemoglobin AI,. Similarly, radioactivity was 
recovered in both glucose and mannose following chromatog- 
raphy of a hydrolysate of albumin obtained at 200 h from the 
buffer, and the effluent was monitored for both protein and glucose 
radioactivity. Arrows indicate position of elution of IgM, IgG, and 
albumin, respectively. 
FIG. 4 (right). In vitro incorporation of [6-‘HIglucose into human 
serum albumin in the presence and absence of aspirin. One hundred 
three nmol (7 mg) of human serum albumin were incubated in 1 ml 
of Dulbecco’s phosphate-buffered saline (9) containing 5 mM glucose, 
2 x 10’ cpm of [6-JH]glucose, with 0.5 mM aspirin (0---O) or without 
aspirin (X--X). Aliquots were removed at indicated times and acid- 
precipitable radioactivity was determined as described under “Mate- 
rials and Methods.” Data are expressed as radioactivity in total 
incubation. 
incubation described in Fig. 3. The ratio of glucose to mannose, 
-4:l, was comparable to that described for hemoglobin AI,, 
-3:l (12). 
We next attempted to separate the in vitro glucosylated 
albumin from unmodified albumin by chromatographic meth- 
ods. Following dialysis of albumin incubated with [6-3H]glu- 
case for 130 h, under conditions described in Fig. 4, the 
albumin was resolved into two distinct fractions upon chro- 
matography on carboxymethylcellulose (Fig. 5A). The fast 
moving fraction (I) contained 30% of the protein and more 
than 95% of the radioactivity, while the second fraction (II) 
contained the remaining 70% of protein, but only trace 
amounts of radioactivity. These two fractions together ac- 
counted for 100% of the applied protein (A*& and radioactiv- 
ity. 
The glucosylated albumin in Peak I of Fig. 5A accounted 
for about 108 nmol out of the original 368 nmol, based on 
absorbance measurements. However, based on the specific 
activity of the glucose used (4 x lo3 cpm/nmol), only 46 nmol 
of sugar were present in Peak I. Assuming 1 nmol of glucose/ 
nmol of albumin, there is an apparent discrepancy of about 62 
nmol, or 17% of the total albumin. This discrepancy suggested 
either that there was a major nonglucosylated contaminant in 
Peak I, or that the starting material contained approximately 
17% unlabeled, glucosylated albumin. The former possibility 
was unlikely since polyacrylamide gel electrophoresis of the 
original albumin in both denaturing and nondenaturing sys- 
tems revealed less than 1% contaminating protein (data not 
shown). However, chromatography of this albumin prepara- 
tion on carboxymethylcellulose, shown in Fig. 5B, clearly 
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The observation that the albumin-containing molecular 
weight fraction of serum proteins was most highly gluco- 
sylated in vitro was also consistent with the known reactivity 
of a few low pK lysine residues in albumin (11). 
FRACTION 
The in vitro observations are physiologically relevant, how- 
ever, only if glucosylated albumin (and other serum proteins) 
can be demonstrated in normal serum. The development of a 
chromatographic procedure which reliably separated the in 
vitro glucosylated from unmodified albumin permitted us to 
detect and quantitate the naturally glucosylated albumin de- 
rivative in normal serum. The detection of glucosylated al- 
bumin in vivo suggests that other plasma proteins glucosy- 
D 
2 
lated in vitro will also be found as glucosylated derivatives in 
w uivo. The electrophoretic and isoelectric heterogeneity of al- 
2 
bumin and the other plasma proteins undoubtedly depend to 
some extent on this post-translational modification. The pre- 
vious characterization of glucosylated hemoglobin and the 
findings described here suggest that the already extensive list 
of stable post-translational modifications of proteins, recently 
reviewed by Uy and Wold (13), should be expanded to include 
the ketoamine derivatives of proteins at lysine and NH2- 
terminal residues. 
FIG. 5. Separation of human serum albumin into glucosylated and 
nonglucosylated components by chromatography on carboxymethyl- 
cellulose. Samples in 0.01 M sodium acetate, pH 4.65, were applied to 
a column (17.5 x 2 cm) of carboxymethylcellulose and washed with 
10 column volumes of starting buffer. The column was eluted using a 
150.ml gradient of 0.01 to 0.5 M sodium acetate, pH 4.65. The start of 
the gradient elution is indicated by the arrow. Fraction size = 1 ml. 
A, chromatography of albumin following in vitro glucosylation with 
16-‘Hlglucose. B, chromatography of albumin isolated from human 
serum: Peahs Z and ZZ were each divided into three equal pools (by 
volume) and tested for ketoamine structures (A,,.,.J by the thiobarbi- 
turic acid assay (9). 
revealed two peaks of protein, one running exactly where 
radioactivity was recovered from in vitro incubations using 
[B-“HIglucose. The material in Peak I of Fig. 5B represented 
13% of the total absorbance, very close to the 17% predicted 
from the previous experiment. In addition, when subjected to 
the thiobarbituric acid assay for ketoamine adducts of protein, 
a strong positive test was obtained across Peak I, while Peak 
II yielded a very low, but reproducible response. 
Glucosylation, as a chemical insult to protein, may be 
physiologically significant in determining the basal rates of 
catabolism of plasma proteins. The resultant disturbance in 
the homeostatic equilibria between protein synthesis and ca- 
tabolism may be a factor in the gradual development of the 
pathophysiology of diabetes. Glucosylation could also affect 
the function, and possibly the turnover, of other proteins 
exposed to the high glucose concentration of the extracellular 
fluid, including proteins in basement membranes, as well as 
plasma membranes of endothelial cells, blood cells, and plate- 
lets. 
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